Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

855 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potential impact of combined high- and low-risk human papillomavirus infection on the progression of cervical intraepithelial neoplasia 2.
Okadome M, Saito T, Tanaka H, Nogawa T, Furuta R, Watanabe K, Kita T, Yamamoto K, Mikami M, Takizawa K; Japanese Gynecologic Oncology Group (JGOG). Okadome M, et al. Among authors: takizawa k. J Obstet Gynaecol Res. 2014 Feb;40(2):561-9. doi: 10.1111/jog.12202. Epub 2013 Oct 22. J Obstet Gynaecol Res. 2014. PMID: 24147758
Current surgical principle for uterine cervical cancer of stages Ia2, Ib1, and IIa1 in Japan: a survey of the Japanese Gynecologic Oncology Group.
Mikami M, Aoki Y, Sakamoto M, Shimada M, Takeshima N, Fujiwara H, Matsumoto T, Kita T, Takizawa K; Disease Committee of Uterine Cervical and Vulvar Cancer, Japanese Gynecologic Oncology Group. Mikami M, et al. Among authors: takizawa k. Int J Gynecol Cancer. 2013 Nov;23(9):1655-60; quiz 1661-2. doi: 10.1097/IGC.0000000000000005. Int J Gynecol Cancer. 2013. PMID: 24172100
Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women.
Fujiwara H, Suzuki M, Takeshima N, Takizawa K, Kimura E, Nakanishi T, Yamada K, Takano H, Sasaki H, Koyama K, Ochiai K. Fujiwara H, et al. Among authors: takizawa k. Tumour Biol. 2015 Feb;36(2):1045-53. doi: 10.1007/s13277-014-2738-7. Epub 2014 Oct 19. Tumour Biol. 2015. PMID: 25326813 Free PMC article.
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer.
Aoki Y, Ochiai K, Lim S, Aoki D, Kamiura S, Lin H, Katsumata N, Cha SD, Kim JH, Kim BG, Hirashima Y, Fujiwara K, Kim YT, Kim SM, Chung HH, Chang TC, Kamura T, Takizawa K, Takeuchi M, Kang SB. Aoki Y, et al. Among authors: takizawa k. Br J Cancer. 2018 Aug;119(5):530-537. doi: 10.1038/s41416-018-0206-7. Epub 2018 Aug 3. Br J Cancer. 2018. PMID: 30072745 Free PMC article. Clinical Trial.
Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
Yamaguchi S, Nishimura R, Yaegashi N, Kiguchi K, Sugiyama T, Kita T, Kubushiro K, Kokawa K, Hiura M, Mizutani K, Yamamoto K, Takizawa K. Yamaguchi S, et al. Among authors: takizawa k. Oncol Rep. 2012 Aug;28(2):487-93. doi: 10.3892/or.2012.1814. Epub 2012 May 14. Oncol Rep. 2012. PMID: 22614251 Clinical Trial.
Surgical principles for managing stage IB2, IIA2, and IIB uterine cervical cancer (Bulky Tumors) in Japan: a survey of the Japanese Gynecologic Oncology Group.
Mikami M, Aoki Y, Sakamoto M, Shimada M, Takeshima N, Fujiwara H, Matsumoto T, Kita T, Takizawa K; Disease Committee of Uterine Cervical and Vulvar Cancer, Japanese Gynecologic Oncology Group. Mikami M, et al. Among authors: takizawa k. Int J Gynecol Cancer. 2014 Sep;24(7):1333-40. doi: 10.1097/IGC.0000000000000202. Int J Gynecol Cancer. 2014. PMID: 25078340
[Modified radical hysterectomy].
Sakamoto K, Takizawa K. Sakamoto K, et al. Among authors: takizawa k. Nihon Rinsho. 2012 Jun;70 Suppl 4:209-12. Nihon Rinsho. 2012. PMID: 23156244 Japanese. No abstract available.
855 results